BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 31299134)

  • 1. Dynamic Aha1 co-chaperone binding to human Hsp90.
    Oroz J; Blair LJ; Zweckstetter M
    Protein Sci; 2019 Sep; 28(9):1545-1551. PubMed ID: 31299134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hsp90 structure and function studied by NMR spectroscopy.
    Didenko T; Duarte AM; Karagöz GE; Rüdiger SG
    Biochim Biophys Acta; 2012 Mar; 1823(3):636-47. PubMed ID: 22155720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aha1 regulates Hsp90's conformation and function in a stoichiometry-dependent way.
    Mondol T; Silbermann LM; Schimpf J; Vollmar L; Hermann B; Tych KK; Hugel T
    Biophys J; 2023 Sep; 122(17):3458-3468. PubMed ID: 37515325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integration of the accelerator Aha1 in the Hsp90 co-chaperone cycle.
    Li J; Richter K; Reinstein J; Buchner J
    Nat Struct Mol Biol; 2013 Mar; 20(3):326-31. PubMed ID: 23396352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric Regulation Points Control the Conformational Dynamics of the Molecular Chaperone Hsp90.
    Rehn A; Moroni E; Zierer BK; Tippel F; Morra G; John C; Richter K; Colombo G; Buchner J
    J Mol Biol; 2016 Nov; 428(22):4559-4571. PubMed ID: 27663270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for recruitment of the ATPase activator Aha1 to the Hsp90 chaperone machinery.
    Meyer P; Prodromou C; Liao C; Hu B; Mark Roe S; Vaughan CK; Vlasic I; Panaretou B; Piper PW; Pearl LH
    EMBO J; 2004 Feb; 23(3):511-9. PubMed ID: 14739935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological and structural basis for Aha1 regulation of Hsp90 ATPase activity in maintaining proteostasis in the human disease cystic fibrosis.
    Koulov AV; LaPointe P; Lu B; Razvi A; Coppinger J; Dong MQ; Matteson J; Laister R; Arrowsmith C; Yates JR; Balch WE
    Mol Biol Cell; 2010 Mar; 21(6):871-84. PubMed ID: 20089831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 'active life' of Hsp90 complexes.
    Prodromou C
    Biochim Biophys Acta; 2012 Mar; 1823(3):614-23. PubMed ID: 21840346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A chemical compound inhibiting the Aha1-Hsp90 chaperone complex.
    Stiegler SC; Rübbelke M; Korotkov VS; Weiwad M; John C; Fischer G; Sieber SA; Sattler M; Buchner J
    J Biol Chem; 2017 Oct; 292(41):17073-17083. PubMed ID: 28851842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for recruitment of the ATPase activator Aha1 to the Hsp90 chaperone machinery.
    Meyer P; Prodromou C; Liao C; Hu B; Roe SM; Vaughan CK; Vlasic I; Panaretou B; Piper PW; Pearl LH
    EMBO J; 2004 Mar; 23(6):1402-10. PubMed ID: 15039704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of Plasmodium falciparum co-chaperone Aha1 supports its interaction with and regulation of Hsp90 in the malaria parasite.
    Chua CS; Low H; Lehming N; Sim TS
    Int J Biochem Cell Biol; 2012 Jan; 44(1):233-45. PubMed ID: 22100910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aha-type co-chaperones: the alpha or the omega of the Hsp90 ATPase cycle?
    LaPointe P; Mercier R; Wolmarans A
    Biol Chem; 2020 Mar; 401(4):423-434. PubMed ID: 31782942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hsp90 Oligomers Interacting with the Aha1 Cochaperone: An Outlook for the Hsp90 Chaperone Machineries.
    Lepvrier E; Moullintraffort L; Nigen M; Goude R; Allegro D; Barbier P; Peyrot V; Thomas D; Nazabal A; Garnier C
    Anal Chem; 2015 Jul; 87(14):7043-51. PubMed ID: 26076190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymmetric activation of the hsp90 dimer by its cochaperone aha1.
    Retzlaff M; Hagn F; Mitschke L; Hessling M; Gugel F; Kessler H; Richter K; Buchner J
    Mol Cell; 2010 Feb; 37(3):344-54. PubMed ID: 20159554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential modulation of functional dynamics and allosteric interactions in the Hsp90-cochaperone complexes with p23 and Aha1: a computational study.
    Blacklock K; Verkhivker GM
    PLoS One; 2013; 8(8):e71936. PubMed ID: 23977182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p23 and Aha1.
    Rehn AB; Buchner J
    Subcell Biochem; 2015; 78():113-31. PubMed ID: 25487019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large Rotation of the N-terminal Domain of Hsp90 Is Important for Interaction with Some but Not All Client Proteins.
    Daturpalli S; Knieß RA; Lee CT; Mayer MP
    J Mol Biol; 2017 May; 429(9):1406-1423. PubMed ID: 28363677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Hsp90 chaperone machinery: conformational dynamics and regulation by co-chaperones.
    Li J; Soroka J; Buchner J
    Biochim Biophys Acta; 2012 Mar; 1823(3):624-35. PubMed ID: 21951723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-chaperone regulation of conformational switching in the Hsp90 ATPase cycle.
    Siligardi G; Hu B; Panaretou B; Piper PW; Pearl LH; Prodromou C
    J Biol Chem; 2004 Dec; 279(50):51989-98. PubMed ID: 15466438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p23 and Aha1: Distinct Functions Promote Client Maturation.
    Biebl MM; Buchner J
    Subcell Biochem; 2023; 101():159-187. PubMed ID: 36520307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.